Key facts

Active Substance
  • atorvastatin (calcium trihydrate)
  • Indapamide
  • perindopril arginine
Therapeutic area
Cardiovascular diseases
Decision number
P/0333/2018
PIP number
EMEA-002395-PIP01-18
Pharmaceutical form(s)
Capsule (hard)
Condition(s) / indication(s)
Treatment of cardiovascular disease
Route(s) of administration
Oral use
Contact for public enquiries

Les Laboratoires Servier

E-mail: mail.pip.enquiries@servier.com 
Tel. +33 1557 26000

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date

Decision

P/0333/2018: EMA decision of 8 October 2018 on the granting of a product-specific waiver for atorvastatin (calcium trihydrate) / perindopril (arginine) / indapamide (EMEA-002395-PIP01-18)

How useful do you find this page?